Amgen earnings Q4 2018

Ricardo Dearatanha | Los Angeles Times | Getty Images

A research associate performs a buffer exchange for protein formulation at AMGEN, a drug research and development laboratory.

Shares of Amgen fell 3 percent in extended trading after the company issued weak 2019 guidance, which overshadowed its better-than-expected fourth-quarter earnings, after the market close on Tuesday.

Source link

Leave a Comment

Insys exec gave doctor lap dance while promoting drug, witness saysTinned food - healthy enough?